Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
171.00    2.60 (1.54%)
Bid:
171.20
Ask:
171.80
Spread: 0.60 (0.35%)
Market Cap: £416.08m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Trading Statement

15 Feb 2024 07:00

RNS Number : 1880D
Sabre Insurance Group PLC
15 February 2024
 

 

 

15 February 2024

 

Sabre Insurance Group plc

Trading Update

 

Sabre Insurance Group Plc ("Sabre" or the "Group"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the year ended 31 December 2023.

Since 2022 Sabre has taken rapid and decisive pricing actions to mitigate the on-going elevated claims inflation. Consequently, it now expects to deliver a strong result for 2023 as it continues to re-build toward its historical level of profitability.

The results are anticipated to meet or exceed current market expectations across almost all key measures, specifically:

- Gross Written Premium at c.£225m, representing 31% growth. Within this, core Motor Vehicle premium growth of circa 47%

- Profit to be towards or slightly above the upper end of current market expectations

- Strong capital generation leaving pre-dividend solvency capital ratio around 205%

Sabre is scheduled to present its audited full year results for 2023 on 19 March 2024.

 

 

Investor enquiries

01306 747 272

Sabre Insurance Group plc

investor.relations@sabre.co.uk

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Teneo

sabre@teneo.com

James Macey White

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR.

 

FORWARD-LOOKING STATEMENTS DISCLAIMER

Cautionary statement

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect Sabre's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to Sabre's business, results of operations, financial position, prospects, growth or strategies and the industry in which it operates.

Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, Sabre disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

The Sabre Insurance Group plc LEI number is 2138006RXRQ8P8VKGV98.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIGDDDGBDGSS
Date   Source Headline
11th Jul 202510:55 amRNSDirector/PDMR Shareholding
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
17th Jun 20254:35 pmRNSDirector/PDMR Shareholding
11th Jun 20251:38 pmRNSDirector/PDMR Shareholding
5th Jun 202511:16 amRNSDirector/PDMR Shareholding
22nd May 202511:38 amRNSResult of AGM
22nd May 20257:00 amRNSTrading Update
13th May 20253:18 pmRNSDirector/PDMR Shareholding
17th Apr 20259:40 amRNSDirector/PDMR Shareholding
11th Apr 20251:26 pmRNSDirector/PDMR Shareholding
10th Apr 20251:09 pmRNSDirector/PDMR Shareholding
8th Apr 20254:31 pmRNSDirector/PDMR Shareholding
8th Apr 20253:54 pmRNSDirector/PDMR Shareholding
8th Apr 20251:53 pmRNSDirector/PDMR Shareholding
4th Apr 20253:20 pmRNSNotice of AGM
27th Mar 20258:37 amRNSDirector/PDMR Shareholding
20th Mar 202511:39 amRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSFinal Results
11th Mar 20251:21 pmRNSDirector/PDMR Shareholding
24th Feb 202511:23 amRNSNotice of Results
11th Feb 20253:12 pmRNSDirector/PDMR Shareholding
13th Jan 20252:14 pmRNSDirector/PDMR Shareholding
11th Dec 202411:57 amRNSDirector/PDMR Shareholding
5th Dec 20247:00 amRNSCapital Markets Event
21st Nov 202410:28 amRNSAppointment of Joint Corporate Broker
12th Nov 20241:15 pmRNSDirector/PDMR Shareholding
23rd Oct 20244:13 pmRNSHolding(s) in Company
22nd Oct 20242:43 pmRNSDirector/PDMR Shareholding
22nd Oct 20242:40 pmRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update
18th Oct 20243:25 pmRNSHolding(s) in Company
11th Oct 202412:40 pmRNSDirector/PDMR Shareholding
26th Sep 20241:25 pmRNSDirector/PDMR Shareholding
11th Sep 202412:21 pmRNSDirector/PDMR Shareholding
11th Sep 20249:51 amRNSHolding(s) in Company
6th Sep 20242:29 pmRNSHolding(s) in Company
30th Aug 202411:50 amRNSDirector/PDMR Shareholding
22nd Aug 20244:22 pmRNSHolding(s) in Company
14th Aug 20243:33 pmRNSHolding(s) in Company
13th Aug 202412:48 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSHalf-year Report 2024
22nd Jul 20247:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.